Lupus Nephritis Clinical Trials

301 clinical trials for Lupus Nephritis across international registries, including 75 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis — RECRUITING · PHASE1
• Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone — RECRUITING · PHASE4
• A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease — RECRUITING · PHASE1
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants — RECRUITING · PHASE2
• A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G — RECRUITING · PHASE2
• PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis — RECRUITING · PHASE4
• Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN) — RECRUITING · PHASE2
• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V — RECRUITING · PHASE2
• A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis — RECRUITING · PHASE2
• Wellness & Workforce Solution for Lupus/Lupus Nephritis — RECRUITING · NA
• Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial) — RECRUITING · PHASE4
• The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population — RECRUITING · PHASE4
• Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) — RECRUITING · PHASE3
• The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases — RECRUITING · PHASE1
• Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN — RECRUITING
• Biomarker Development for Autoimmune Disorders Involving the Kidneys — RECRUITING
• CHT105 for the Treatment of Refractory Lupus Nephritis — RECRUITING · NA
• A Study of KITE-363 in Participants With Refractory Autoimmune Diseases — RECRUITING · PHASE1
• CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus — RECRUITING · PHASE1
• US Zamto-cel Autoimmune Diseases — RECRUITING · PHASE1
• A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) — RECRUITING · PHASE1
• A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) — RECRUITING · PHASE2
• Dapagliflozin in Active Lupus Nephritis — RECRUITING · PHASE4
• A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease — RECRUITING · PHASE1
• Lupus Landmark Study: A Prospective Registry and Biorepository — RECRUITING
• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders — RECRUITING · PHASE1
• SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus — RECRUITING · PHASE1
• RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus — RECRUITING · PHASE1
• A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) — RECRUITING · PHASE1
• A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease — RECRUITING · PHASE1
• The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study — RECRUITING · PHASE2
• The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment — RECRUITING · PHASE2
• Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus — RECRUITING · PHASE1
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis — RECRUITING · PHASE1
• Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN — RECRUITING · PHASE2
• Research Accelerated by You Lupus Registry — RECRUITING
• Phase IIa Study for IPG11406 in Patients With Lupus Nephritis — RECRUITING · PHASE1
• VIBRANT: VIB4920 for Active Lupus Nephritis — RECRUITING · PHASE2
• Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF — RECRUITING · PHASE3
• Safety and Efficacy of ONT01 in Lupus — RECRUITING · PHASE1
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis — RECRUITING · PHASE2
• Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial — RECRUITING · PHASE4
• LUPKYNIS Drug-use Results Survey — RECRUITING
• Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis — RECRUITING · NA
• Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells — RECRUITING · PHASE2
• A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus — RECRUITING · PHASE1
• Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) — RECRUITING

Refine this search